Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Is Less More? Does Decreasing OnabotulinumtoxinA Injection Sites in the Bladder Increase Patient Satisfaction While Maintaining Efficacy?

NCT03523091 is registered in ClinicalTrials.gov with Corewell Health East as lead sponsor.

NCT NCT03523091
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03523091 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Is Less More? Does Decreasing OnabotulinumtoxinA Injection Sites in the Bladder Increase Patient Satisfaction While Maintaining Efficacy?
Lead sponsor
Corewell Health East
Phase
Phase 4
Overall status
Terminated
Start date
August 8, 2018
Completion date
September 1, 2020
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder, overactive bladder syndrome, urinary bladder, overactive, urinary frequency/urgency, urinary incontinence, urinary urgency